MINNEAPOLIS, July 16 /PRNewswire-FirstCall/ -- Uroplasty, Inc. (AMEX:UPI) announced today that David Kaysen, President and CEO, and Medi Jiwani, Vice President, CFO & Treasurer, will present at the Capstone Small-Cap Investor Conference in Milwaukee, Wisconsin on July 17, 2007 at 10.00 am central time. Presentation slides will available for viewing on Uroplasty's website (http://www.uroplasty.com/) starting at 10.00 am central time on July 17, 2007.
Uroplasty, Inc., headquartered in Minnetonka, Minnesota, with wholly-owned subsidiaries in The Netherlands and the United Kingdom, is a medical device company that develops, manufactures and markets innovative, proprietary products for the treatment of voiding dysfunctions. Our minimally invasive products treat urinary and fecal incontinence, symptoms of overactive bladder and vesicoureteral reflux. Additionally, some of our soft-tissue bulking agent products are used for the treatment of vocal cord rehabilitation and for augmentation or restoration of soft tissue defects in plastic surgery indications. Some of our products are not approved for use in the U.S.
FOR FURTHER INFORMATION: visit Uroplasty's web page at http://www.uroplasty.com/ or contact Mr. Kaysen, President & CEO, or Medi Jiwani, Vice President, CFO and Treasurer. DATASOURCE: Uroplasty, Inc.
CONTACT: David B. Kaysen of Uroplasty, Inc., +1-952-426-6140 Web site: http://www.uroplasty.com/
|